FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics:705.000000|Direction: 1|PValue:0.000880982|FDR:0.0612282;FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:614.000000|Direction:-1|PValue:0.041768946|FDR:0.4260465;FeatureName:preoperative_pretreatment_cea_level|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.315144|Direction:-1|PValue:0.011877921|FDR:0.7329800;FeatureName:residual_tumor|Type:CAT|StatisticMethod:kruskal|GroupComparison:r0/r2/rx/r1|Statistics: 10.527311|Direction: 1|PValue:0.014576772|FDR:0.1602295;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics: 11.147350|Direction: 1|PValue:0.010955206|FDR:0.1278052;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:  6.283303|Direction: 1|PValue:0.043211374|FDR:0.1297261;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics:418.000000|Direction:-1|PValue:0.011371560|FDR:0.0687238;FeatureName:MLH1_silencing|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:232.000000|Direction:-1|PValue:0.019831307|FDR:0.0984483;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:272.000000|Direction:-1|PValue:0.009721528|FDR:0.0386084;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.260342|Direction: 1|PValue:0.027198676|FDR:0.0900147;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.263058|Direction: 1|PValue:0.025579876|FDR:0.0911693;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:328.000000|Direction:-1|PValue:0.045890126|FDR:0.1876096;FeatureName:RYR2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:420.000000|Direction:-1|PValue:0.049640758|FDR:0.3285745;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.259881|Direction:-1|PValue:0.014476513|FDR:0.0428135;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.234472|Direction:-1|PValue:0.027889411|FDR:0.0760123;FeatureName:8q24.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.248661|Direction:-1|PValue:0.019485018|FDR:0.5159243;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.277598|Direction:-1|PValue:0.008830617|FDR:0.0280598;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.287225|Direction:-1|PValue:0.006661422|FDR:0.0243668;FeatureName:10q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.252454|Direction: 1|PValue:0.017647092|FDR:0.5527197;FeatureName:3p14.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.229006|Direction:-1|PValue:0.031860452|FDR:0.1850361;FeatureName:10q23.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.241808|Direction: 1|PValue:0.023224663|FDR:0.5380380;FeatureName:7q31.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics: -0.356082|Direction:-1|PValue:0.000661858|FDR:0.0183996;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  0.249830|Direction: 1|PValue:0.018901749|FDR:0.0611010